SignatureFD’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

SignatureFD’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-501	Closed	-$2K	–	3325
2021 Q3	$2K	Buy	+501	New	+$1.54K	﹤0.01%	2738

Other funds holding INFI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SignatureFD's INFI Position: Q4 2021 in Review

SignatureFD sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2021, closing a stake of 501 shares — an estimated $2K sold.

SignatureFD first reported a position in INFI in Q3 2021 and held it in 1 quarter. The position peaked at $2K in Q3 2021. 97 funds tracked by Wall St. Rank hold INFI as of Q4 2021.

SignatureFD reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
SignatureFD sold 501 Infinity Pharmaceuticals, Inc. shares in Q4 2021, an estimated $2K.
SignatureFD first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2021 and held it in 1 quarter.
SignatureFD's Infinity Pharmaceuticals, Inc. position peaked at $2K in Q3 2021.
97 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2021.

Based on SignatureFD's 13F filing for Q4 2021, filed 25 Jan 2022.